Grail, Inc.
Clinical trials sponsored by Grail, Inc., explained in plain language.
-
Blood test could spot hidden cancers early in thousands
Diagnosis OngoingThis trial is testing a new blood test called Galleri that looks for signs of many different cancers. Over 140,000 people aged 50-77 in the UK are taking part to see if adding this test to standard NHS screening helps find cancers at an earlier, more treatable stage. The study co…
Phase: NA • Sponsor: GRAIL, Inc. • Aim: Diagnosis
Last updated May 26, 2026 08:57 UTC
-
Simple blood test could spot hidden cancers before symptoms start
Diagnosis OngoingThis study is testing a new blood test that can detect many types of cancer early, before symptoms appear. About 35,000 people aged 50 and older will take the test, and those with a positive result will get follow-up exams to confirm if they have cancer. The goal is to see if the…
Phase: NA • Sponsor: GRAIL, Inc. • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC
-
14,000 volunteers help test new blood Test's Real-World cancer detection
Knowledge-focused OngoingThis study is watching how the Galleri® blood test, which looks for many types of cancer early, works when used in regular doctor visits. About 14,000 adults who chose to take the test are taking part. The goal is to see how well the test finds cancer signals and how patients fee…
Sponsor: GRAIL, Inc. • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC